Kyn can interact with aryl hydrocarbon receptor (AHR) on TAMs and other immune cells to repress pro-inflammatory cytokine release by TAMs and drive CD39 expression in TAMs, which contributes to T cell dysfunction while promoting Treg generation in GBM [56,57]. The gene discussed is AHR; the disease is glioblastoma.